Andrew A. Taylor Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Biography and Research Information
OverviewAI-generated summary
Andrew A. Taylor's research has explored the potential of a peptidomimetic N-heterocycle, NEOS-223, as an anticancer agent and P-glycoprotein inhibitor. This work involved pre-clinical evaluation of the compound's efficacy. In addition to his work in health and medical research, Taylor has also published on topics related to media and communication, specifically analyzing speech acts and conversation within a television series. He has also investigated the historical and cultural representation of Vikings in media. Taylor's scholarly output includes 13 publications, with a total of 106 citations and an h-index of 3.
Metrics
- h-index: 3
- Publications: 13
- Citations: 106
Selected Publications
-
Tattoos, “Tattoos,” Vikings, “Vikings,” and Vikings (2022)
Collaboration Network
Top Collaborators
- Abstract P39: Pre-clinical evaluation of NEOS-223, an (S)-valine-thiazole derived peptidomimetic N-heterocycle, as an anticancer agent and P-glycoprotein inhibitor
- Abstract P39: Pre-clinical evaluation of NEOS-223, an (S)-valine-thiazole derived peptidomimetic N-heterocycle, as an anticancer agent and P-glycoprotein inhibitor
- Abstract P39: Pre-clinical evaluation of NEOS-223, an (S)-valine-thiazole derived peptidomimetic N-heterocycle, as an anticancer agent and P-glycoprotein inhibitor
- Abstract P39: Pre-clinical evaluation of NEOS-223, an (S)-valine-thiazole derived peptidomimetic N-heterocycle, as an anticancer agent and P-glycoprotein inhibitor
- Abstract P39: Pre-clinical evaluation of NEOS-223, an (S)-valine-thiazole derived peptidomimetic N-heterocycle, as an anticancer agent and P-glycoprotein inhibitor
Similar Researchers
Based on overlapping research topics